Black Friday saleUp to 70% OFF
BIOCRYST PHARMACEUTICALS, INCBIOCRYST PHARMACEUTICALS, INCBIOCRYST PHARMACEUTICALS, INC

BIOCRYST PHARMACEUTICALS, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

BCRX chart


Full chart

BCRX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪32.06 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.97 MXN
Net income (FY)
‪−3.85 B‬ MXN
Revenue (FY)
‪5.63 B‬ MXN
Shares float
‪196.10 M‬
Beta (1Y)
0.87

Employees


Employees (FY)
536
Change (1Y)
+5 +0.94%
Revenue / Employee (1Y)
‪618.31 K‬ MXN
Net income / Employee (1Y)
‪−422.65 K‬ MXN

About BioCryst Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Jon P. Stonehouse
Website
biocryst.com
Headquarters
Durham
Founded
1986
FIGI
BBG00PGGX3P1
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BCRX news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BCRX is 155.00 MXN — it has increased by 38.39% in the past 24 hours. Watch BIOCRYST PHARMACEUTICALS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BIOCRYST PHARMACEUTICALS, INC stocks are traded under the ticker BCRX.
BCRX stock has fallen by −1.05% compared to the previous week, the month change is a 45.32% rise, over the last year BIOCRYST PHARMACEUTICALS, INC has showed a 45.32% increase.
We've gathered analysts' opinions on BIOCRYST PHARMACEUTICALS, INC future price: according to them, BCRX price has a max estimate of 606.72 MXN and a min estimate of 161.79 MXN. Watch BCRX chart and read a more detailed BIOCRYST PHARMACEUTICALS, INC stock forecast: see what analysts think of BIOCRYST PHARMACEUTICALS, INC and suggest that you do with its stocks.
BCRX stock is 28.80% volatile and has beta coefficient of 0.87. Track BIOCRYST PHARMACEUTICALS, INC stock price on the chart and check out the list of the most volatile stocks — is BIOCRYST PHARMACEUTICALS, INC there?
Today BIOCRYST PHARMACEUTICALS, INC has the market capitalization of ‪31.98 B‬, it has increased by 6.19% over the last week.
Yes, you can track BIOCRYST PHARMACEUTICALS, INC financials in yearly and quarterly reports right on TradingView.
BIOCRYST PHARMACEUTICALS, INC is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BCRX earnings for the last quarter are −1.38 MXN per share, whereas the estimation was −1.36 MXN resulting in a −1.61% surprise. The estimated earnings for the next quarter are −1.53 MXN per share. See more details about BIOCRYST PHARMACEUTICALS, INC earnings.
BIOCRYST PHARMACEUTICALS, INC revenue for the last quarter amounts to ‪2.31 B‬ MXN, despite the estimated figure of ‪2.25 B‬ MXN. In the next quarter, revenue is expected to reach ‪2.62 B‬ MXN.
BCRX net income for the last quarter is ‪−276.50 M‬ MXN, while the quarter before that showed ‪−232.47 M‬ MXN of net income which accounts for −18.94% change. Track more BIOCRYST PHARMACEUTICALS, INC financial stats to get the full picture.
No, BCRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 536.00 employees. See our rating of the largest employees — is BIOCRYST PHARMACEUTICALS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOCRYST PHARMACEUTICALS, INC EBITDA is ‪−775.24 M‬ MXN, and current EBITDA margin is −30.79%. See more stats in BIOCRYST PHARMACEUTICALS, INC financial statements.
Like other stocks, BCRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCRYST PHARMACEUTICALS, INC stock right from TradingView charts — choose your broker and connect to your account.